Eisai, Biogen receives U.S. FDA approval for Alzheimer’s drug, applies for full approval – Reuters

The Friday approval by the U.S. Food and Drug Administration was given Alzheimer’s Eisai Co Ltd developed the drug lecanemab (4523.T) And Biogen Inc